These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 9275719)
1. [Protein kinase inhibitor staurosporine enhances cytotoxicity of antitumor drugs to cancer cells]. Wang RH; Zhang HQ; Fang M; Xue SB Yao Xue Xue Bao; 1996; 31(6):411-5. PubMed ID: 9275719 [TBL] [Abstract][Full Text] [Related]
2. Staurosporine blocked normal cells at G1/S boundary. Wang RH; Xue SB Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):161-5. PubMed ID: 10072972 [TBL] [Abstract][Full Text] [Related]
3. [Changes of intracellular calcium, calmodulin in normal and tumor cells traggered by staurosporine]. Wang RH; Fang M; Xue SB Shi Yan Sheng Wu Xue Bao; 1996 Jun; 29(2):133-9. PubMed ID: 9387792 [TBL] [Abstract][Full Text] [Related]
4. Potentiation of apoptosis by flavopiridol in mitomycin-C-treated gastric and breast cancer cells. Schwartz GK; Farsi K; Maslak P; Kelsen DP; Spriggs D Clin Cancer Res; 1997 Sep; 3(9):1467-72. PubMed ID: 9815832 [TBL] [Abstract][Full Text] [Related]
5. [Effect of staurosporine on cell cycle of human gastric cancer cells]. Ha MW; Hou KZ; Liu YP; Yuan Y Ai Zheng; 2003 Jul; 22(7):691-4. PubMed ID: 12866957 [TBL] [Abstract][Full Text] [Related]
6. [Antitumor effects of specific cyclooxygenase inhibitors combined with chemotherapeutic agents on gastric cancer cells in vitro]. Zhu FS; Chen XM; Wang YJ; Zhang X; Feng JX Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):186-8. PubMed ID: 17649633 [TBL] [Abstract][Full Text] [Related]
7. Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents. Pogrebniak A; Schemainda I; Azzam K; Pelka-Fleischer R; Nüssler V; Hasmann M Eur J Med Res; 2006 Aug; 11(8):313-21. PubMed ID: 17052966 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis. Nandy P; Lien EJ; Avramis VI Anticancer Res; 1999; 19(3A):1625-33. PubMed ID: 10470093 [TBL] [Abstract][Full Text] [Related]
9. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines. Hashitani S; Urade M; Nishimura N; Maeda T; Takaoka K; Noguchi K; Sakurai K Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902 [TBL] [Abstract][Full Text] [Related]
10. Enhancement of Fas-mediated apoptosis in renal cell carcinoma cells by adriamycin. Wu XX; Mizutani Y; Kakehi Y; Yoshida O; Ogawa O Cancer Res; 2000 Jun; 60(11):2912-8. PubMed ID: 10850437 [TBL] [Abstract][Full Text] [Related]
11. Effects of all-trans-retinoic on human gastric cancer cells BGC-823. Zhang JP; Chen XY; Li JS J Dig Dis; 2007 Feb; 8(1):29-34. PubMed ID: 17261132 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of antioxidants and hyperthermia enhance bleomycin-induced cytotoxicity and lipid peroxidation in Chinese hamster ovary cells. Khadir A; Verreault J; Averill DA Arch Biochem Biophys; 1999 Oct; 370(2):163-75. PubMed ID: 10510274 [TBL] [Abstract][Full Text] [Related]
13. Differential sensitivity to mitomycin C between human RSa cell line and its derivative UVr-1. Hiwasa T; Chen Z; Nomura J; Yamamori H; Tashiro T; Nakajima N; Suzuki N Anticancer Res; 1999; 19(5B):3915-20. PubMed ID: 10628331 [TBL] [Abstract][Full Text] [Related]
14. Modulation of the in vitro cytotoxicity of seven anticancer drugs by protein synthesis inhibition using sparsomycin. Zylicz Z; Hofs HP; Wagener DJ; Van Rennes H; Wessels JM; van den Broek LA; Ottenheijm HC Anticancer Res; 1989; 9(6):1835-40. PubMed ID: 2483308 [TBL] [Abstract][Full Text] [Related]
15. Wortmannin, a phosphoinositide 3-kinase inhibitor, selectively enhances cytotoxicity of receptor-directed-toxin chimeras in vitro and in vivo. Davol PA; Bizuneh A; Frackelton AR Anticancer Res; 1999; 19(3A):1705-13. PubMed ID: 10470104 [TBL] [Abstract][Full Text] [Related]
16. [Effect of bleomycin A5 with calmodulin inhibitor on the proliferation of S-180 cells in vitro]. Zhang HQ; He NG; Xue SB Zhongguo Yao Li Xue Bao; 1990 Sep; 11(5):470-3. PubMed ID: 1718143 [TBL] [Abstract][Full Text] [Related]
17. Effects of topoisomerase II inhibitors on gastric cancer cells characterized by different genetic lesions. Scovassi AL; Pellegata NS; Di Stefano L; Padovan L; Negri C; Prosperi E; Riva F; Ciomei M; Ranzani GN Anticancer Res; 2001; 21(4A):2803-8. PubMed ID: 11724358 [TBL] [Abstract][Full Text] [Related]
18. Antitumor effects and drug interactions of the proteasome inhibitor bortezomib (PS341) in gastric cancer cells. Fujita T; Doihara H; Washio K; Ino H; Murakami M; Naito M; Shimizu N Anticancer Drugs; 2007 Jul; 18(6):677-86. PubMed ID: 17762396 [TBL] [Abstract][Full Text] [Related]
19. Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression. Notarbartolo M; Poma P; Perri D; Dusonchet L; Cervello M; D'Alessandro N Cancer Lett; 2005 Jun; 224(1):53-65. PubMed ID: 15911101 [TBL] [Abstract][Full Text] [Related]
20. [Enhancement of antitumor activity of bleomycin A5 in mouse sarcoma 180 cells in vitro and in vivo by verapamil]. He NG; Zhang HQ; Wang RH; Yang XL; Xue SB Zhongguo Yao Li Xue Bao; 1990 Jul; 11(4):381-4. PubMed ID: 1716815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]